Stay updated on ONC201 + Nivolumab in MSS mCRC Clinical Trial
Sign up to get notified when there's something new on the ONC201 + Nivolumab in MSS mCRC Clinical Trial page.

Latest updates to the ONC201 + Nivolumab in MSS mCRC Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the study content, replacing the previously visible details with a standard error page and blocking access to study information and related resources.SummaryDifference19%

- Check44 days agoChange DetectedThe revision tag on the study record was updated from v3.6.5 to v3.6.6, indicating an administrative update to the page history. This change does not alter the study data or how the trial details are presented.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page revision indicator was updated from v3.6.4 to v3.6.5, indicating a newer version of the page is now live. This reflects a version update rather than a specific change to the trial details.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4. This indicates a new version of the page was published.SummaryDifference0.1%

- Check100 days agoChange DetectedPage revision updated from v3.6.2 to v3.6.3, indicating a new version of the page.SummaryDifference0.1%

Stay in the know with updates to ONC201 + Nivolumab in MSS mCRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ONC201 + Nivolumab in MSS mCRC Clinical Trial page.